Publication | Open Access

The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge

VaccinationNanomedicineCross-protectionLethal Influenza ChallengeInnate Immune AgonistsVaccine TargetImmunologyInfluenza VaccineInnate ImmunityNanolipoprotein ParticlesVaccine DesignImmunotherapyMedicineEgg-based Vaccine ProductionInfluenza Vaccines